Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TELK -- Telik, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (48)	12/13/2000 7:19:51 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 887

Subject: Join Us Tomorrow (12/14/00) for Bio Online's Chemokines "Live Online Discussion Forum" Event Date: Wed, 13 Dec 2000 14:49:39 -0800 From: kchi@bio.com Hello, Thank you for your interest in Bio Online Forum "Live Panel Discussion" Events. If you would like your e-mail address removed from the event list, please send back a reply with a request for removal. Bio Online's upcoming "In Focus - Live Panel Discussion" is entitled, "ADVANCES IN RESEARCH: Chemokines and their Receptors in Human Health". We want to be sure that you can plan to join us tomorrow, December 14th from 5-6:00 PM Pacific Time. Chemokines are a family of small molecular weight proteins whose primary function is to control the migration of immune cells through lymphoid organs and other tissues. They exert their effects through binding to seven-transmembrane G-protein coupled receptors on the target cell's surface. It has recently become clear that chemokines and their receptors play an important role in a wide variety of diseases including inflammatory disorders, cancer and infectious diseases, such as HIV. Bio Online has assembled a panel of experts from academia and industry to discuss latest advances in our understanding of the biology of chemokines and chemokine receptors in health and disease and their potential as pharmacological targets. Panelists include: James Campbell, Ph.D., Assistant Professor, Department of Medicine, Harvard University John P. Moore, Ph.D., Professor of Microbiology and Immunology, Joan and Sanford I. Weill Medical College of Cornell University Thomas J. Schall, Ph.D., President and CEO, ChemoCentryx For additional background information on this topic, you can read "Chemokines and their Receptors", bio.com Please visit bio.com to find out more about this live panel discussion, submit questions for our panelists and... receive complimentary gifts including: - a Ciphergen t-shirt - a Pierce t-shirt Sponsored By: Ciphergen ciphergen.com Pierce piercenet.com We hope to see you on December 14th. Thank you for your interest and support. Best Regards, Bio Online bio.com